Transient increases of growth fraction during fractionated radiation therapy for cervical carcinoma. Ki-67 and PC10 immunostaining.
BACKGROUND
The Ki-67 and PC10 indexes are consistent with the growth and S-phase fractions, respectively.


METHODS
Eighty-three biopsy specimens from 18 patients with cervical squamous cell carcinoma were examined before and during fractionated radiation therapy (RT), using an immunohistochemical method.


RESULTS
The 18 patients were divided into two groups according to the Ki-67 index before RT; those with values of less than 42% (Group A; n = 11) and those with values of 42% or more (Group B; n = 7). The Ki-67 index in Group A increased approximately twofold at radiation doses of 5.4-9 Gy compared with values before RT. The Ki-67 index in Group B, which increased slightly at doses of 5.4-9 Gy, decreased by approximately one-fifth at a dose of 27 Gy, compared with the value before RT. The PC10 indexes in both groups showed little change to doses of 5.4-9 Gy. The mitotic indexes were less than 1% before RT and decreased to a minimum with doses of 18-27 Gy. There was no correlation between the Ki-67 and PC10 indexes before or during RT.


CONCLUSIONS
In cancer tissues with a low growth fraction before RT, radiation doses of 5.4-9 Gy produced increases in the numbers of cycling cancer cells in the G1 or G2 phases. This transient increase possibly was attributable to the combined effects of the recruitment phenomenon and G1 or G2 block.
Oka
K
K
Section of Clinical Laboratory, Hospital, National Institute of Radiological Sciences, Chiba, Japan.
Nakano
T
T
Hoshi
T
T
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000951:Antigens, Neoplasm / Q000032:analysis; D002294:Carcinoma, Squamous Cell / Q000276:immunology / Q000473:pathology* / Q000532:radiotherapy*; D002453:Cell Cycle / Q000528:radiation effects; D002455:Cell Division / Q000528:radiation effects; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen; D008875:Middle Aged; D008940:Mitotic Index; D009363:Neoplasm Proteins / Q000032:analysis; D009687:Nuclear Proteins / Q000032:analysis; D011879:Radiotherapy Dosage; D002583:Uterine Cervical Neoplasms / Q000276:immunology / Q000473:pathology* / Q000532:radiotherapy*
D000951:Antigens, Neoplasm; D019394:Ki-67 Antigen; D009363:Neoplasm Proteins; D009687:Nuclear Proteins